Flower One Announces Full Exercise of Over-Allotment Option Resulting in a Public Offering for Gross Proceeds of $57.5 Million
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
